Latest Breaking News On - The guangzhou sino israel biotech investment fund gibf - Page 1 : comparemela.com

/PRNewswire/ Kamari Pharma announced today the completion of an $8 million investment by the Chinese fund GIBF2, managed by Dr. Shuki Gleitman, Prof. Shlomo.

Carl gengShlomo noyDavid aviezerShuki gleitmanAsaf yarkoniLiora braimanAvner lushiPrnewswire kamari pharmaArkin bioholdingsYork stock exchangeIsrael biotech investment fundProtalix biotherapeuticsNew york stock exchangeLichen simplex chronicusNew york stockSouth china